- Half Year 2023 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 26, 2023€2.06 (-0.72%)Earnings
- Q4 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 07, 2023€3.12 (+14.52%)Earnings
- Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation TranscriptDec 20, 2022
- Q2 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 23, 2022€6.7 (+3.88%)Earnings
- Full Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 08, 2022€13.9 (-13.02%)Earnings
- Mithra Pharmaceuticals SA to Discuss Donesta Top-Line Results Call TranscriptJan 14, 2022
- Half Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2021€18.02 (-2.07%)Earnings
- Full Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 09, 2021€23.2 (+4.98%)Earnings
- Half Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2020€16.68 (-4.14%)Earnings
- Mithra Pharmaceuticals SA at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation Transcript
Presentation
Dec 20, 2022 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Benoit Mathieu
Mithra Pharmaceuticals SA - Group IR Manager
* Christophe Marechal
Mithra Pharmaceuticals SA - CFO
* Graham K. Dixon
Mithra Pharmaceuticals SA - Chief Scientific Officer
* Jean-Manuel Fontaine
Mithra Pharmaceuticals SA - Chief Commercial & External Affairs Officer
* Leon Van Rompay
Mithra Pharmaceuticals SA - CEO
=====================
Conference Call Participants
=====================
* Clément Bassat
Portzamparc BNP Paribas Group, Research Division - Financial Analyst
* Laura Roba
Banque Degroof Petercam S.A., Research Division - Analyst
* Thomas Vranken
KBC Securities NV, Research Division - Equity Analyst of Pharma & Biotech
=====================
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)